Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination

BACKGROUND: The 2-dose recombinant zoster vaccine (RZV) series is recommended for prevention of herpes zoster (HZ) in adults aged ≥50 years, but data are limited on the impact of concomitant administration with other vaccines on subsequent HZ risk. METHODS: This cohort study included Kaiser Permanen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruxvoort, Katia J, Qian, Lei, Wu, Jun, Florea, Ana, Ackerson, Bradley, Sy, Lina S, Vega Daily, Leticia, Takhar, Harpreet, Tseng, Hung Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825562/
https://www.ncbi.nlm.nih.gov/pubmed/35146050
http://dx.doi.org/10.1093/ofid/ofac011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825562/
https://www.ncbi.nlm.nih.gov/pubmed/35146050
http://dx.doi.org/10.1093/ofid/ofac011

Ejemplares similares